CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk Healthcare Procter & Gamble Health Ltd

Procter & Gamble Health Ltd

BSE 500126 PGHL INE199A01012
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

17 filings · 4 material · busiest 2026-08-12

What it files

Filings

17 in the window

  1. 12 August 2026

    AGM / EGM

    Notice Calling The 59Th Annual General Meeting Of The Company.

    Enclosed herewith is the Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company, scheduled on Thursday, September 3, 2026 at 2:30 p.m.

    AGM/EGM / AGM View filing →

  2. 12 August 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for the Financial Year 2025-26 is enclosed for the Annual General Meeting scheduled on Thursday September 3, 2026.

    Others / Reg. 34 (1) Annual Report View filing →

  3. 12 August 2026

    BRSR

    Business Responsibility and Sustainability Reporting (BRSR)

    The BRSR Report for the Financial Year ended March 31, 2026 is enclosed.

    Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

  4. 12 August 2026

    AGM / EGM

    59Th Annual General Meeting Of The Company

    The 59th Annual General Meeting of the Company is scheduled on Thursday, September 3, 2026 at 2:30 PM.

    AGM/EGM / AGM View filing →

  5. 10 August 2026

    Record Date

    Record Date For Purpose Of Dividend

    Record Date for Purpose of Dividend

    Corp. Action / Record Date View filing →

  6. 6 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board Meeting.

    Board Meeting / Outcome of Board Meeting View filing →

  7. 6 August 2026

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    Unaudited Financial Results for the Quarter ended June 30, 2026

    Result / Financial Results View filing →

  8. 6 August 2026

    Press Release

    Press Release / Media Release

    Press Release on the Unaudited Financial Results for the Quarter ended June 30, 2026.

    Company Update / Press Release / Media Release View filing →

  9. 15 July 2026

    General

    Update Regarding Company'S Annual General Meeting For The Financial Year 2025-26 And Record Date

    Dear Sir/Madam, Please find attached intimation regarding change in Company's Annual General Meeting date for the Financial Year 2025-26 and record date for purpose of AGM/distribution ....

    Company Update / General View filing →

  10. 3 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Dear Sir, Please find attached signed certificate for confirming compliance under Regulation 74 (5) of the SEBI (DP) Regulations, for the quarter ended June 30, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  11. 26 June 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6, 2026

    Procter & Gamble Health Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Dear Sir, In terms ....

    Board Meeting / Board Meeting View filing →

  12. 26 June 2026

    Trading Window

    Closure of Trading Window

    Dear Sir, Please find attached our intimation for closure of trading window.

    Insider Trading / SAST / Closure of Trading Window View filing →

  13. 26 June 2026

    General

    Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Inc ome From Procter & Gamble Health Limited ('The Company')

    Dear Sir, Please find attached communication in respect of deduction of TDS on the amount of final dividend income from the Company, if approved by the shareholders at the ensuing AGM.

    Company Update / General View filing →

  14. 25 June 2026

    Change in Management

    Change in Management

    Pursuant to regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you regarding changes in the Senior Management Personnel of the Company shall take place effective July 1, 2026.

    Company Update / Change in Management View filing →

  15. 18 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The Company has informed the Stock Exchange regarding the Presentation of the Analyst/Institutional investor meet scheduled to be held today.

    Company Update / Analyst / Investor Meet View filing →

  16. 18 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    The Company has informed the Stock Exchange regarding the transcript and link to the recording of the analyst/institutional investors meeting held earlier today.

    Company Update / Analyst / Investor Meet View filing →

  17. 4 June 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    We wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts ....

    Company Update / Analyst / Investor Meet View filing →